FDA Drug Approval, N013217, SKELAXIN

FDA Drug Approval, N013217, SKELAXIN

Regular price $89.00 USD
Regular price Sale price $89.00 USD
Sale Sold out
NDA: 013217
Company: KING PHARMS
Drug Name: SKELAXIN
Active Ingredients: METAXALONE
Strength: TABLET;ORAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: STANDARD
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details